Biochemical markers predictive for bone marrow involvement in systemic mastocytosis

Marjolein L. Donker, Jasper J. van Doormaal*, Frederiek F. van Doormaal, Philip M. Kluin, Eveline van der Veer, Jan G. R. de Monchy, Ido P. Kema, Hanneke C. Kluin-Nelemans

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

17 Citations (Scopus)
230 Downloads (Pure)

Abstract

Systemic mastocytosis is characterized by bone marrow involvement, which requires a bone marrow biopsy for diagnostic work-up. We questioned whether bone marrow involvement could be predicted using biochemical markers. We selected patients with various symptoms suggestive of indolent systemic mastocytosis, of whom 63 ultimately had bone marrow involvement. Patients suspected of aggressive mastocytosis, or mastocytosis associated with other hematologic diseases were excluded. Evaluation of 115 patients and 15 patient controls demonstrated a test accuracy for serum tryptase, urinary N- methylhistamine and N- methylimidazole acetic acid of 96%, 88% and 95% respectively. These markers provide an excellent pre-test probability of indolent systemic mastocytosis.

Original languageEnglish
Pages (from-to)120-123
Number of pages4
JournalHaematologica-the Hematology Journal
Volume93
Issue number1
DOIs
Publication statusPublished - Jan-2008

Keywords

  • mastocytosis
  • bone marrow involvement
  • biochemical markers
  • tryptase
  • N-iota methylhistamine
  • N-iota methylimidazole acetic acid
  • BLOOD MONONUCLEAR-CELLS
  • C-KIT
  • MUTATION
  • ADULTS
  • URINE

Fingerprint

Dive into the research topics of 'Biochemical markers predictive for bone marrow involvement in systemic mastocytosis'. Together they form a unique fingerprint.

Cite this